Get started
Author

JiMin Park

Observed names: Jimin Park, Park, JiMin
ORCID: 0009-0005-7468-0875
Observed ORCID: 0009-0005-7468-0875
OpenAlex ID: A5121783260
HBE‐843, a Novel, Potent, and Selective EGFR Targeting PROTAC for the Treatment of Non‐Small‐Cell Lung Cancer
2026 · Mohammad Hassan Baig, Chang Joong Kim, et al. · Archiv der Pharmazie · 3
Abstract 5793: First-in-class potent and selective oral KAT6A degrader development candidate, PRT13722, drives complete tumor regressions as a monotherapy with an improved pre-clinical hematological safety profile
2026 · Monisha Sivakumar, Sarah Pawley, et al. · Cancer Research · 2
1-oxa-3,7-diazaspiro[4.5]decan-2-one derivatives as potent KRAS-G12D inhibitors: A multidisciplinary approach integrating machine learning, synthesis, and biological evaluation
2026 · Sungwook Ryu, Mohammad Hassan Baig, et al. · Computers in Biology and Medicine · 1
Design, synthesis and biological evaluation of novel KRAS-G12D inhibitors
2026 · Mohammad Hassan Baig, Yun Seong Jo, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry
PDF
Figure S10 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S6 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S2 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Table S4 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Table S6 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S1 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S4 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S11 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S5 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Table S5 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Table S7 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S3 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Table S1 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S8 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Data from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Table S2 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S9 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Table S3 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S7 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Design, synthesis and biological evaluation of novel KRAS-G12D inhibitors
2026 · Baig, Mohammad Hassan, Jo, Yun Seong, et al. · Figshare
Works count: 24
Citation count: 6
H-index: 2
I10-index:
Year
Topic
Type